oral semaglutide cardiovascular benefit Indications for The impact of oral semaglutide

The slower erosion curve for biologics (20-30% biosimilar market share after two years, versus 80-90% for small molecules) means that even after formal loss of exclusivity, the price compression that Cost Plus needs to add a drug to its formulary at a meaningful patient savings may not materialize for three to four years post-LOE

First quarter net income was up to $1.77 billion, or $1.41 per share, compared to $1.11 billion, or 88 cents in the year-ago quarter

In the ACHIEVE3 trial, the drug demonstrated stronger blood sugar reduction than Novo Nordisks oral semaglutide

For estimated changes for selected procedures, we refer readers to Table 168